Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1111/bph.15092

http://scihub22266oqcxt.onion/10.1111/bph.15092
suck pdf from google scholar
32368792!7267399!32368792
unlimited free pdf from europmc32368792    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32368792      Br+J+Pharmacol 2020 ; 177 (14): 3147-3161
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Potential therapeutic targets and promising drugs for combating SARS-CoV-2 #MMPMID32368792
  • Zhou H; Fang Y; Xu T; Ni WJ; Shen AZ; Meng XM
  • Br J Pharmacol 2020[Jul]; 177 (14): 3147-3161 PMID32368792show ga
  • As of April 9, 2020, a novel coronavirus (SARS-CoV-2) had caused 89,931 deaths and 1,503,900 confirmed cases worldwide, which indicates an increasingly severe and uncontrollable situation. Initially, little was known about the virus. As research continues, we now know the genome structure, epidemiological and clinical characteristics, and pathogenic mechanisms of SARS-CoV-2. Based on this knowledge, potential targets involved in the processes of virus pathogenesis need to be identified, and the discovery or development of drugs based on these potential targets is the most pressing need. Here, we have summarized the potential therapeutic targets involved in virus pathogenesis and discuss the advances, possibilities, and significance of drugs based on these targets for treating SARS-CoV-2. This review will facilitate the identification of potential targets and provide clues for drug development that can be translated into clinical applications for combating SARS-CoV-2.
  • |Adenosine Monophosphate/analogs & derivatives/therapeutic use[MESH]
  • |Alanine/analogs & derivatives/therapeutic use[MESH]
  • |Angiotensin II Type 1 Receptor Blockers/therapeutic use[MESH]
  • |Angiotensin-Converting Enzyme 2[MESH]
  • |Angiotensin-Converting Enzyme Inhibitors/therapeutic use[MESH]
  • |Antiviral Agents/therapeutic use[MESH]
  • |Basigin/metabolism[MESH]
  • |Benzamidines[MESH]
  • |Betacoronavirus/*genetics/metabolism/pathogenicity[MESH]
  • |COVID-19[MESH]
  • |COVID-19 Drug Treatment[MESH]
  • |COVID-19 Serotherapy[MESH]
  • |COVID-19 Vaccines[MESH]
  • |Coronavirus Infections/complications/*drug therapy/immunology/metabolism/prevention & control/therapy[MESH]
  • |Cytokine Release Syndrome/drug therapy/etiology/immunology[MESH]
  • |Esters[MESH]
  • |Gabexate/analogs & derivatives/therapeutic use[MESH]
  • |Genome, Viral[MESH]
  • |Guanidines/therapeutic use[MESH]
  • |Humans[MESH]
  • |Immunization, Passive[MESH]
  • |Immunosuppressive Agents/therapeutic use[MESH]
  • |Medicine, Chinese Traditional[MESH]
  • |Nucleic Acid Synthesis Inhibitors/therapeutic use[MESH]
  • |Pandemics[MESH]
  • |Peptidyl-Dipeptidase A/metabolism[MESH]
  • |Pneumonia, Viral/complications/*drug therapy/immunology/metabolism[MESH]
  • |Protease Inhibitors/therapeutic use[MESH]
  • |RNA-Dependent RNA Polymerase/metabolism[MESH]
  • |SARS-CoV-2[MESH]
  • |Serine Endopeptidases/metabolism[MESH]
  • |Spike Glycoprotein, Coronavirus/metabolism[MESH]
  • |Viral Vaccines[MESH]
  • |Virus Internalization[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box